Laboratorios Farmaceuticos Rovi, S.A. Stock CBOE
Stocks
0ILL
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time
CBOE
02:30:00 09/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 59.25 EUR | 0.00% |
|
0.00% | -1.74% |
| 05/10 | Spanish stocks - Factors to watch on Oct 5 | RE |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 2.97B 3.33B 2.77B 2.52B 4.74B 323B 4.79B 33.31B 13.03B 164B 12.5B 12.23B 527B | P/E 2026 * |
19.6x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.97B 3.32B 2.77B 2.51B 4.73B 322B 4.77B 33.21B 12.99B 163B 12.47B 12.2B 526B | EV / Sales 2026 * |
3.83x | EV / Sales 2027 * | 3.25x |
| Free-Float |
31.63% | Yield 2026 * |
1.67% | Yield 2027 * | 2% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
Tradegate
| 41L | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 month | -0.59% | ||
| 3 months | +4.73% | ||
| 6 months | -26.19% | ||
| Current year | -1.74% |
| 1 week | 59.25 |  | 59.25 |
| 1 month | 59.25 | | 59.6 |
| 3 years | 46.36 | | 90.3 |
| 5 years | 35.3 | | 90.3 |
| 10 years | 10.95 | | 90.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +0.81% | +17.21% | 3.33B | |
| -1.61% | +1.72% | +38.30% | +106.93% | 1,043B | |
| -0.76% | -0.84% | +35.21% | +62.70% | 618B | |
| +0.39% | +4.81% | +17.81% | +83.77% | 481B | |
| -0.29% | -0.99% | +64.79% | +37.06% | 351B | |
| +1.57% | +3.53% | +21.90% | +42.67% | 338B | |
| +1.10% | +2.22% | +11.54% | +34.94% | 269B | |
| +1.70% | +1.80% | -6.62% | +11.31% | 244B | |
| -1.37% | +0.04% | +38.29% | +52.33% | 220B | |
| +0.17% | -0.27% | +24.40% | +96.82% | 182B | |
| Average | +0.27% | +0.28% | +24.64% | +54.57% | 416.3B | |
| Weighted average by Cap. | +0.01% | +0.60% | +30.61% | +69.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 867M 722M 656M 1.23B 83.95B 1.25B 8.67B 3.39B 42.66B 3.25B 3.18B 137B | 892M 999M 833M 756M 1.42B 96.79B 1.44B 10B 3.91B 49.18B 3.75B 3.67B 158B |
| Net income | 146M 164M 136M 124M 233M 15.86B 235M 1.64B 641M 8.06B 615M 602M 25.92B | 173M 194M 161M 147M 276M 18.75B 278M 1.94B 757M 9.53B 727M 711M 30.64B |
| Net Debt | -8.5M -9.52M -7.93M -7.2M -13.55M -922M -13.69M -95.19M -37.23M -468M -35.74M -34.96M -1.51B | -72.51M -81.2M -67.64M -61.44M -116M -7.86B -117M -812M -318M -4B -305M -298M -12.85B |
| Date | Price | Change |
|---|---|---|
| 08/10/26 | EUR 59.25 | -3.03% |
| 07/10/26 | EUR 61.10 | 0.00% |
| 06/10/26 | EUR 61.10 | 0.00% |
| 05/10/26 | EUR 61.10 | 0.00% |
| 02/10/26 | EUR 61.10 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- 0ILL Stock
Select your edition
All financial news and data tailored to specific country editions
